Combined thrombolysis with abciximab and rtPA in patients with middle cerebral artery occlusion

Acta Neurologica Scandinavica

Volumn 121, Issue 1, 2010, Pages 63-66

  Gahn, G ^a,b   Barlinn, K ^a   Dzialowski, I ^a   Puetz, V ^a   Kunz, A ^a   Hentschel, H ^a   Becker, U ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b General Hospital Karlsruhe   (Germany)

Author keywords

Computed tomography; GP IIb IIIa inhibitors; MCA occlusion; Thrombolysis

Indexed keywords

ABCIXIMAB; ALTEPLASE;

ADULT; BLOOD CLOT LYSIS; BRAIN DECOMPRESSION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CRANIECTOMY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HEMORRHAGIC INFARCTION; HOSPITAL DISCHARGE; HUMAN; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NOTE; RANKIN SCALE; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFARCTION, MIDDLE CEREBRAL ARTERY; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 74049112012     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01241.x     Document Type: Note

References (14)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 : 1581 1587.
2. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008 359 : 1317 1329.
3. Hacke W, Albers G, Al-Rawi Y et al. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005 36 : 66 73.
4. Saqqur M, Uchino K, Demchuk AM et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007 38 : 948 954.
5. Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999 282 : 2003 2011.
6. Hill MD, Rowley HA, Adler F et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003 34 : 1925 1931.
7. Antman EM, Giugliano RP, Gibson CM et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999 99 : 2720 2732.
8. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial. Stroke 2005 36 : 880 890.
9. Straub S, Junghans U, Jovanovic V, Wittsack HJ, Seitz RJ, Siebler M. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke 2004 35 : 705 709.
10. Adams HP Jr., Effron MB, Torner J et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008 39 : 87 99.
11. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998 352 : 1245 1251.
12. Broderick JP, Lu M, Kothari R et al. Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke 2000 31 : 2335 2341.
13. Junghans U, Seitz RJ, Wittsack HJ, Aulich A, Siebler M. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein IIb/IIIa inhibitor: report of four cases. Radiology 2001 221 : 795 801.
14. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008 7 : 299 309.